Gilead Sciences-Regulators-Truvada

US experts urge approval of first AIDS prevention pill

US health advisers urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people. read more..

source:http://yhoo.it/LvWxkB

US experts urge approval of first AIDS prevention pill

US health advisers urged regulators to approve Truvada, made by Gilead Sciences, as the first preventive pill against HIV/AIDS instead of just a treatment for infected people. read more..

source:http://yhoo.it/LvWxkB

Food And Drug Administration-Gilead Sciences-Hiv Infection

FDA panel backs first pill to block HIV infection

The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS. read more..

source:http://yhoo.it/LvWxkA

FDA panel backs first pill to block HIV infection

The first drug shown to prevent HIV infection won the endorsement of a panel of federal advisers Thursday, clearing the way for a landmark approval in the 30-year fight against the virus that causes AIDS. read more..

source:http://yhoo.it/LvWxkA

HIV Infection Rates-Gilead Sciences-Hiv Infection-AIDS Drugs

Using AIDS drugs to prevent infection: a bargain?

CHICAGO (Reuters) - Giving an AIDS-fighting drug to men who are at high risk of HIV infection would cost billions, but it might be worth it terms of reducing infection rates, U.S. researchers said on Monday. Since 2010, when a landmark study in the New England Journal of Medicine found that giving a daily dose of Gilead Sciences' Truvada to men who have sex with men can reduce HIV infection rates by 44 percent, researchers have been trying to work out how to make this treatment approach financially feasible. ... read more..

source:http://yhoo.it/ISYEBf

Human Immunodeficiency Virus-Food And Drug Administration-Aids Healthcare Foundation

HIV pill for prevention debated as FDA ruling nears

(Reuters) - An advocacy group concerned about costs and possible Health Problems related to a drug being considered to help stop the spread of HIV infection to healthy people has asked U.S. regulators to delay or deny its approval. Los Angeles-based AIDS Healthcare Foundation (AHF) has petitioned the Food And Drug Administration on the grounds that studies have shown that the pill, Truvada, made by Gilead Sciences, is only partially effective in preventing transmission. The drug is already approved to treat people infected with the human immunodeficiency virus that causes AIDS. ... read more..

source:http://yhoo.it/wNkd9B